ROI Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.06M Sell
9,848
-205
-2% -$208K 5.42% 5
2025
Q4
$10.8M Sell
10,053
-552
-5% -$528K 6.2% 4
2025
Q3
$8.09M Sell
10,605
-696
-6% -$518K 4.83% 5
2025
Q2
$8.81M Sell
11,301
-382
-3% -$297K 5.6% 4
2025
Q1
$9.65M Sell
11,683
-287
-2% -$239K 7.01% 1
2024
Q4
$9.24M Sell
11,970
-1,028
-8% -$851K 6.29% 3
2024
Q3
$11.5M Sell
12,998
-794
-6% -$714K 7.95% 2
2024
Q2
$12.5M Sell
13,792
-166
-1% -$133K 9.08% 2
2024
Q1
$10.9M Sell
13,958
-1,792
-11% -$1.28M 8.54% 1
2023
Q4
$9.18M Buy
+15,750
New +$9.19M 7.6% 1

Other funds holding LLY

ROI Financial Advisors's LLY Position: Q1 2026 in Review

ROI Financial Advisors reduced its Eli Lilly (LLY) stake by 2% in Q1 2026, selling an estimated $208K and leaving 9,848 shares worth $9.06M. The position accounts for 5.42% of the portfolio, ranked #5.

ROI Financial Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $12.5M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • ROI Financial Advisors held 9,848 shares of Eli Lilly worth $9.06M as of Q1 2026.
  • ROI Financial Advisors sold 205 Eli Lilly shares in Q1 2026, an estimated $208K.
  • Eli Lilly made up 5.42% of ROI Financial Advisors's portfolio in Q1 2026, its #5 holding.
  • ROI Financial Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • ROI Financial Advisors's Eli Lilly position peaked at $12.5M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on ROI Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.